ARCUTIS BIOTHERAPEUTICS INC (ARQT)
US03969K1088 - Common Stock
| 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -262.14M | -311.46M | -206.36M | -135.68M | -42.00M | |||
| Depreciation Amortization | 1.52M | 930.00K | 450.00K | 120.00K | 70.00K | |||
| Change In Working Capital | -23.50M | -10.18M | 3.62M | 14.13M | -1.51M | |||
| Interest Paid | 25.45M | 12.64M | 140.00K | N/A | N/A | |||
| Other non cash items | 37.06M | 62.98M | 27.66M | 8.39M | 600.00K | |||
| OPERATING CASH FLOW | -247.06M | -257.72M | -174.63M | -113.03M | -42.84M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -428.00K | -23.28M | -1.00M | -320.00K | -300.00K | |||
| Other Investing Activity | 180.66M | -63.92M | -74.96M | -181.50M | -26.03M | |||
| INVESTING CASH FLOW | 180.23M | -87.20M | -75.95M | -181.82M | -26.33M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | 0.00 | 125.00M | 73.99M | N/A | 0.00 | |||
| Stock Issued/Repurchased | 101.32M | 178.99M | 209.60M | 298.15M | 94.50M | |||
| Other Financing Activity | 0.00 | -2.19M | -1.64M | 0.00 | -1.40M | |||
| FINANCING CASH FLOW | 101.32M | 301.80M | 281.95M | 298.15M | 93.10M | |||
| Exchange Rate Effect | -50.00K | N/A | N/A | N/A | N/A | |||
| CHANGE IN CASH | 34.45M | -43.12M | 31.37M | 3.30M | 23.93M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -247.06M | -257.72M | -174.63M | -113.03M | -42.84M | |||
| Capital Expenditure | -428.00K | -23.28M | -1.00M | -320.00K | -300.00K | |||
| FREE CASH FLOW | -247.49M | -281.00M | -175.63M | -113.35M | -43.14M | |||
All data in USD